New Mexico P.R.N.

Information updated as of 10/2007: 


Editor’s Note: At this time I do not have any Pharmacists as possible contacts for Pharmacists seeking
                       recovery to network with. If you would be interest, let me know. Thanks, Charlie Broussard

Model: Health Care Organization (government entity)

Contracted Treatment Provider - Eligible for Pharmacists, Student Pharmacist and Technicians

New Mexico Monitored Treatment Program (MTP)

Location and hours:
The MTP offices are located in Albuquerque New Mexico:
 2500 Louisiana NE Suite 250, Albuquerque, NM 87110
Phone: 505-271-0800

MTP website Info: http://monitoredtreatment.com

Executive Director

Andrea P. Newman, PhD, LMFT, LADAC provides administration, fiscal management, program oversight, liaison to contracting boards and other agencies, outreach, education and consultation to health professionals and health professional practice arenas, manages the drug screen coordination program, and provides support and consultation to the MTP Clinical Program. 
505-271-0800 or mtp@monitoredtreatment.com

Medical Director 

Daniel A. Collins, MD is a practicing Psychiatrist with expertise in addiction medicine. He is also certified as a Medical Review Officer (MRO). He co-manages the MTP Clinical Program with the Clinical Coordinator. He also provides administrative support and outreach. 
505-271-1914 or dcollins@monitoredtreatment.com

Clinical Coordinator

Mary Lynn Griffin, MA, LMHC provides assessment, referral, and monitoring and co-managing the MTP Clinical Program. She also provides administrative support and outreach. 
505-323-9393 or mlgriffin@monitoredtreatment.com


A Good and Helpful Contact Person: Suzie Clark       
E-Mail Addresses: SuzieC2@aol.com


***************************************************************************************************************************************

The New Mexico impaired pharmacist program is now being administered by the New Mexico Monitored Treatment Program. The PRN hopes that it will continue to be an active support group.

Observation from the Editor: It was difficult to communicate with the Monitored Treatment Program.  I don't think
they are very much  aware of the PRN program aside from getting pharmacist participants in their counseling 
programs, supervising the urine screens and keeping their contract with the board.